牛乳腺炎治療システムの世界市場2024~2028

◆英語タイトル:Global Bovine Mastitis Treatment System Market 2024-2028

Technavioが発行した調査報告書(IRTNTR77458-24)◆商品コード:IRTNTR77458-24
◆発行会社(リサーチ会社):Technavio
◆発行日:2024年2月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

牛乳腺炎治療システムの世界市場 2024-2028
牛乳腺炎治療システム市場は、2023年から2028年にかけて551.33百万米ドルの成長が予測され、予測期間中のCAGRは5.34%で加速すると予測されています。この調査レポートは、牛乳腺炎治療システム市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。

現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、乳房炎の有病率の増加、食品の安全性と品質の重視の高まり、PLF技術と牛乳腺炎治療システムの統合によって牽引されています。

Technavioの牛乳腺炎治療システム市場は以下のように区分されます:

製品別
• 抗生物質
• その他

投与経路別
• 乳房内
• 全身投与

地域別
• 北米
• ヨーロッパ
• アジア
• その他の地域(ROW)

本調査では、自動検出システムと精密医療の出現と採用が、今後数年間の牛乳腺炎治療システム市場の成長を促進する主な理由の1つであると特定しています。また、乳房炎管理のための非抗生物質療法の採用の増加と動物福祉に対する意識の高まりは、市場の大きな需要につながります。

牛乳腺炎治療システム市場に関するレポートは以下の分野をカバーしています:
• 牛乳腺炎治療システム市場のサイジング
• 牛乳腺炎治療システム市場予測
• 牛乳腺炎治療システム市場産業分析

本レポートでは、牛乳腺炎治療システム市場の主要ベンダーとして、Advanced Animal Diagnostics、Armenta、Bio-Vet、Boehringer Ingelheim International GmbH、Ceva Sante Animale、Elanco Animal Health Inc、 Endovac Animal Health、Forte Healthcare Ltd.、HIPRA S A、Huvepharma EOOD、ImmuCell Corp.、Merck KGaA、Neogen Corp.、Nimrod Veterinary Products Ltd.、Norbrook Laboratories Ltd.、Vetoquinol SA、Virbac Group、West Way Health、Zoetis Inc.、Thermo Fisher Scientific Inc.などが掲載されています。。また、牛乳腺炎治療システム市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場および企業状況プが含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 牛乳腺炎治療システムの世界市場:製品別
7 牛乳腺炎治療システムの世界市場:投与経路別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global bovine mastitis treatment system market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global bovine mastitis treatment system market 2018 – 2022 ($ million)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.3 Route of Administration Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Antibiotics – Market size and forecast 2023-2028
o Exhibit 34: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
o 6.4 Others – Market size and forecast 2023-2028
o Exhibit 38: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 44: Chart on Route of Administration – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Route of Administration – Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 46: Chart on Comparison by Route of Administration
o Exhibit 47: Data Table on Comparison by Route of Administration
o 7.3 Intramammary – Market size and forecast 2023-2028
o Exhibit 48: Chart on Intramammary – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Intramammary – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Intramammary – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Intramammary – Year-over-year growth 2023-2028 (%)
o 7.4 Systemic – Market size and forecast 2023-2028
o Exhibit 52: Chart on Systemic – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Systemic – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Systemic – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Systemic – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 56: Market opportunity by Route of Administration ($ million)
o Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 India – Market size and forecast 2023-2028
o Exhibit 83: Chart on India – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on India – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on India – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on India – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 France – Market size and forecast 2023-2028
o Exhibit 95: Chart on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Advanced Animal Diagnostics
o Exhibit 107: Advanced Animal Diagnostics – Overview
o Exhibit 108: Advanced Animal Diagnostics – Product / Service
o Exhibit 109: Advanced Animal Diagnostics – Key offerings
o 12.4 Bio-Vet
o Exhibit 110: Bio-Vet – Overview
o Exhibit 111: Bio-Vet – Product / Service
o Exhibit 112: Bio-Vet – Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 113: Boehringer Ingelheim International GmbH – Overview
o Exhibit 114: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 115: Boehringer Ingelheim International GmbH – Key news
o Exhibit 116: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 117: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Ceva Sante Animale
o Exhibit 118: Ceva Sante Animale – Overview
o Exhibit 119: Ceva Sante Animale – Product / Service
o Exhibit 120: Ceva Sante Animale – Key offerings
o 12.7 Elanco Animal Health Inc.
o Exhibit 121: Elanco Animal Health Inc. – Overview
o Exhibit 122: Elanco Animal Health Inc. – Product / Service
o Exhibit 123: Elanco Animal Health Inc. – Key offerings
o 12.8 Endovac Animal Health
o Exhibit 124: Endovac Animal Health – Overview
o Exhibit 125: Endovac Animal Health – Product / Service
o Exhibit 126: Endovac Animal Health – Key offerings
o 12.9 HIPRA S A
o Exhibit 127: HIPRA S A – Overview
o Exhibit 128: HIPRA S A – Product / Service
o Exhibit 129: HIPRA S A – Key offerings
o 12.10 ImmuCell Corp.
o Exhibit 130: ImmuCell Corp. – Overview
o Exhibit 131: ImmuCell Corp. – Business segments
o Exhibit 132: ImmuCell Corp. – Key offerings
o Exhibit 133: ImmuCell Corp. – Segment focus
o 12.11 Merck KGaA
o Exhibit 134: Merck KGaA – Overview
o Exhibit 135: Merck KGaA – Business segments
o Exhibit 136: Merck KGaA – Key news
o Exhibit 137: Merck KGaA – Key offerings
o Exhibit 138: Merck KGaA – Segment focus
o 12.12 Nimrod Veterinary Products Ltd.
o Exhibit 139: Nimrod Veterinary Products Ltd. – Overview
o Exhibit 140: Nimrod Veterinary Products Ltd. – Product / Service
o Exhibit 141: Nimrod Veterinary Products Ltd. – Key offerings
o 12.13 Norbrook Laboratories Ltd.
o Exhibit 142: Norbrook Laboratories Ltd. – Overview
o Exhibit 143: Norbrook Laboratories Ltd. – Product / Service
o Exhibit 144: Norbrook Laboratories Ltd. – Key offerings
o 12.14 Thermo Fisher Scientific Inc.
o Exhibit 145: Thermo Fisher Scientific Inc. – Overview
o Exhibit 146: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 147: Thermo Fisher Scientific Inc. – Key news
o Exhibit 148: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 149: Thermo Fisher Scientific Inc. – Segment focus
o 12.15 Vetoquinol SA
o Exhibit 150: Vetoquinol SA – Overview
o Exhibit 151: Vetoquinol SA – Business segments
o Exhibit 152: Vetoquinol SA – Key news
o Exhibit 153: Vetoquinol SA – Key offerings
o Exhibit 154: Vetoquinol SA – Segment focus
o 12.16 Virbac Group
o Exhibit 155: Virbac Group – Overview
o Exhibit 156: Virbac Group – Business segments
o Exhibit 157: Virbac Group – Key news
o Exhibit 158: Virbac Group – Key offerings
o Exhibit 159: Virbac Group – Segment focus
o 12.17 Zoetis Inc.
o Exhibit 160: Zoetis Inc. – Overview
o Exhibit 161: Zoetis Inc. – Business segments
o Exhibit 162: Zoetis Inc. – Key news
o Exhibit 163: Zoetis Inc. – Key offerings
o Exhibit 164: Zoetis Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global bovine mastitis treatment system market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Route of Administration – Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Intramammary – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Intramammary – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Intramammary – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Intramammary – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Systemic – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Systemic – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Systemic – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Systemic – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on India – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on India – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on India – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on India – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on France – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Advanced Animal Diagnostics – Overview
Exhibits108: Advanced Animal Diagnostics – Product / Service
Exhibits109: Advanced Animal Diagnostics – Key offerings
Exhibits110: Bio-Vet – Overview
Exhibits111: Bio-Vet – Product / Service
Exhibits112: Bio-Vet – Key offerings
Exhibits113: Boehringer Ingelheim International GmbH – Overview
Exhibits114: Boehringer Ingelheim International GmbH – Business segments
Exhibits115: Boehringer Ingelheim International GmbH – Key news
Exhibits116: Boehringer Ingelheim International GmbH – Key offerings
Exhibits117: Boehringer Ingelheim International GmbH – Segment focus
Exhibits118: Ceva Sante Animale – Overview
Exhibits119: Ceva Sante Animale – Product / Service
Exhibits120: Ceva Sante Animale – Key offerings
Exhibits121: Elanco Animal Health Inc. – Overview
Exhibits122: Elanco Animal Health Inc. – Product / Service
Exhibits123: Elanco Animal Health Inc. – Key offerings
Exhibits124: Endovac Animal Health – Overview
Exhibits125: Endovac Animal Health – Product / Service
Exhibits126: Endovac Animal Health – Key offerings
Exhibits127: HIPRA S A – Overview
Exhibits128: HIPRA S A – Product / Service
Exhibits129: HIPRA S A – Key offerings
Exhibits130: ImmuCell Corp. – Overview
Exhibits131: ImmuCell Corp. – Business segments
Exhibits132: ImmuCell Corp. – Key offerings
Exhibits133: ImmuCell Corp. – Segment focus
Exhibits134: Merck KGaA – Overview
Exhibits135: Merck KGaA – Business segments
Exhibits136: Merck KGaA – Key news
Exhibits137: Merck KGaA – Key offerings
Exhibits138: Merck KGaA – Segment focus
Exhibits139: Nimrod Veterinary Products Ltd. – Overview
Exhibits140: Nimrod Veterinary Products Ltd. – Product / Service
Exhibits141: Nimrod Veterinary Products Ltd. – Key offerings
Exhibits142: Norbrook Laboratories Ltd. – Overview
Exhibits143: Norbrook Laboratories Ltd. – Product / Service
Exhibits144: Norbrook Laboratories Ltd. – Key offerings
Exhibits145: Thermo Fisher Scientific Inc. – Overview
Exhibits146: Thermo Fisher Scientific Inc. – Business segments
Exhibits147: Thermo Fisher Scientific Inc. – Key news
Exhibits148: Thermo Fisher Scientific Inc. – Key offerings
Exhibits149: Thermo Fisher Scientific Inc. – Segment focus
Exhibits150: Vetoquinol SA – Overview
Exhibits151: Vetoquinol SA – Business segments
Exhibits152: Vetoquinol SA – Key news
Exhibits153: Vetoquinol SA – Key offerings
Exhibits154: Vetoquinol SA – Segment focus
Exhibits155: Virbac Group – Overview
Exhibits156: Virbac Group – Business segments
Exhibits157: Virbac Group – Key news
Exhibits158: Virbac Group – Key offerings
Exhibits159: Virbac Group – Segment focus
Exhibits160: Zoetis Inc. – Overview
Exhibits161: Zoetis Inc. – Business segments
Exhibits162: Zoetis Inc. – Key news
Exhibits163: Zoetis Inc. – Key offerings
Exhibits164: Zoetis Inc. – Segment focus
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 牛乳腺炎治療システムの世界市場2024~2028(Global Bovine Mastitis Treatment System Market 2024-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆